# Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

> **NCT05776277** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Cook MyoSite** · enrollment: 200 (estimated)

## Conditions studied

- Fecal Incontinence

## Interventions

- **BIOLOGICAL:** Iltamiocel
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05776277
- **Lead sponsor:** Cook MyoSite
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-21
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05776277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05776277, "Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05776277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*